Clinical Trials Browser

Phase 1/2 × Recurrence × Bevacizumab × Clear all

NCT06859775 2025-06-06

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

Phase 1/2 Recruiting

Uterine Cervical Neoplasms, Recurrence